FedEx, General Mills And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Why Steelcase Stock Tanked After-Hours
Steelcase Inc. (NYSE: SCS) shares are trading lower in Tuesday's after-hours session after the company reported mixed third-quarter financial results.
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
Amidst fanfare for Nasdaq 100, U.S. small-cap stocks rally, with Russell 2000 index reaching levels not seen since Aug. 2022, 80% of stocks trading above 50-day MA, outperforming large caps & Tech-heavy QQQ ETF by 11.4% (MTD)
What’s Up With JinMed Stock?
JIN MEDICAL INTERNATIONAL LTD. (NASDAQ: ZJYL) shares are trading higher on Tuesday.
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis’ Drug
Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c
Do Psychedelic Treatments Always Require Psychotherapy? Some Say Yes, Others Think It’s ‘Reductionism’
The question of whether psychedelic treatments always require psychotherapy is one hotly debated among researchers, and answers -as well as backstories- vary throughout the whole spectrum.
Fueling Concerns: Analyst Downgrades Vertex Energy Amid Refining Industry Challenges
Stifel analyst Michael E.
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What’s Driving Markets Tuesday?
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758 days since their previous peak.
FY24 Election Is A Major Game Changer For US Renewable Sector: Piper Analyst
Piper Sandler analyst Kashy Harrison revised the rating on several Renewables & Alternative Energy companies.
The analyst sees benefits accruing to the installers initially (FY24) and inverters eventually (FY25), with the rest of the stock in the coverage benefiting in the long term.
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.
Compugen shares jumped 204.1% to $2.22 on Tuesday.